Which of the following conditions can result in a drug being classified as both adulterated and misbranded?

A drug can be classified as both adulterated and misbranded when it has inaccurate strength. When the strength of a medication does not match what is claimed on the label, it can pose a significant risk to patient safety, potentially leading to underdosage or overdosage of the active ingredient. This discrepancy can make the drug adulterated because it fails to meet the appropriate quality and identity standards established for pharmaceuticals, which are necessary to ensure safety and efficacy.

Additionally, inaccurate labeling regarding the strength also leads to misbranding since the drug's labeling is false or misleading in any particular way. Misbranding fundamentally involves incorrect information concerning the drug, which, in this case, includes the critical aspect of its strength. Thus, when a drug is misbranded due to inaccurate strength, it aligns with adulteration standards, reinforcing the importance of proper labeling and drug integrity in pharmacy practice.

In contrast, while damaged packaging, exceeding expiration dates, and improper storage can lead to issues with drug quality and integrity, they do not necessarily align with both classifications simultaneously in the same way inaccurate strength does. For example, damaged packaging may lead to misbranding but does not inherently affect the strength and quality like inaccurate strength does. Similarly, exceeding expiration dates or incorrect storage conditions